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ABSTRACT 
Mushrooms are used for a variety of biotechnological applications, particularly for the production of food, enzymes, dietary supplements, 
pharmaceutical compounds, feed supplements. Basidiomycetes mushroom fungi have been known for their nutritional values they can be 
considered as functional foods which can provide health benefits beyond the traditional nutrients. Mushroom represents a major and untapped 
source of potent new pharmaceutical products. A wide range of activities including antitumour, cardiovascular and antimicrobial are reported in 
mushrooms. In developing countries like India mushroom progress is a boon in the field of food, medicine, and in generating employment. The 
alternative systems of medicine utilize the curative properties of mushrooms. They are also known to possess promising antioxidative, 
cardiovascular, hypercholesterolemia, antimicrobial, hepato-protective and anticancer effects. The present study aimed to evaluate antimicrobial 
and antihaemolytic activities of various extracts of Basidiomycetes mushroom fungi. Different Basidiomycetes mushroom fungi extracts (Hot 
water, Acetone and Hexane) were tested for antimicrobial and antihaemolytic activities. Among these different extracts of Basidiomycetes 
mushroom fungi the hexane extract of Pleurotus pulmonarius showed potential antimicrobial and antihaemolytic activity. The results of this 
study suggest the possibility of using Basidiomycetes mushroom fungi as natural sources for the pharmaceutical industry and could act as safe 
and cost-effective with potential biological activities. These findings encourage studying these fungal strains further for their potential biological 
applications. 
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INTRODUCTION 
Mushrooms have become attractive as a functional food and 
as a source for the development of drugs and nutraceuticals 
responsible with their antioxidant, antitumorand antimicrobial 
properties1,2. Besides their pharmacological features, 
mushrooms are becoming more important in our diet due to 
their nutritional value, related to high protein and low fat / 
energy contents3. Trametes versicolor (L.) Lioyd has been 
considered among the 25 major medicinal macrofungi 
worldwide4, mainly due to its traditional usage. In recent 
years Basidiomycetes and other higher fungi including some 
recognized medicinal mushrooms have been recognized 
medicinal mushrooms have been re-investigated as sources 
of novel antibiotics mainly as a result of increasing difficulty 
and the cost of isolating novel bioactive compounds from the 
Actinomycetes and Streptomycetes5.  
A variety of mushrooms have been used traditionally for the 
maintenance of health and for prevention and treatment of 
diseases such as cancer, inflammation, viral diseases, 
hypercholesterolemia, blood platelet aggregation and 
hypertension 6-10. Medical mycology is as old as traditional 
uses of mushrooms. They have been used in medicine since 
the Neolithic and Paleolithic eras11. 
The present research possesses an idea about the antibiotic 
activity of some of the important edible Basidiomycetes 
mushroom fungi. Several edible mushrooms have 
traditionally been used in China and other countries like 
Japan, Korea, USA etc. An old Chinese proverb regarding 
mushrooms states that “medicine and food have a common 
origin”. At present there are at least 270 species of 
mushrooms that are known to have various therapeutic 
properties like antitumor, anticancer, anti-inflammatory, 
antithrombotic, antidiabetic, antifibrotic, antimicrobial, 
antiviral, anti-hypersensitive, cholesterol reducing, 
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hypogloycemic etc. A few are responsible for lowering of 
blood pressure.  
Pleurotus species have high medicinal value. Compounds 
extracted from these mushrooms exhibit activity against 
various chronic diseases including hypertension, 
hypercholesterolemia12-14. The medicinal beneficial effects of 
Pleurotus species were discovered independently in different 
countries. Oyster mushrooms (Pleurotus species) are 
excellently edible and nutritious, rank among one of the most 
widely cultivated mushrooms in the world15.  
The screening of mushrooms from different ecological and 
geographical regions of India is still required to identify, 
isolate, design, develop, modify or to prepare new 
pharmacologically active compounds from wild mushrooms. 
Considering the immense importance of mushrooms as a 
source of food as well as herbal medicines, the present study 
is dealt with a recent insight on the pharmaceutical potential 
of some edible Basidiomycetes mushroom fungi. 
MATERIALS AND METHODS 
Basidiomycetes Fungi  
The pure cultures of basidiomycetes mushroom fungal 
strains used in the present study were Pleurotus 
citrinopileatus, Pleurotus eous, Pleurotus cystidiosis, Pleurotus 
ostreatus, Pleurotus eryngii, Pleuoruts flabellatus, Pleurotus 
florida, Pleurotus pulmonarius and Schizophyllum commune. 
Pure cultures were maintained in PG and Research Centre in 
Biotechnology, M.G.R. College, Hosur.  
Storage and maintenance of Basidiomycetes fungi 
Pure cultures of fungi were stored at 10°C.  Sub-culturing 
was performed every month to ensure that the organisms 
remained viable.  The mycelial agar plugs (7 mm) from the 
stock cultures were aseptically transferred to fresh Potato 
Dextrose Agar medium and then incubated at room 
temperature (28 ± 2ºC) until confluent growth was achieved.   
Test organisms 
The bacterial strains used throughout this study as test 
organisms for investigating the anti-microbial activity of the 
selected mushroom fungi were Bacillus sp., Proteus sp., and 
Staphylococcus aureus. All the bacterial strains were grown 
in nutrient broth aerobically in Erlenmeyer flasks and were 
stored as nutrient agar slants at 4°C. 
Anti-microbial activity  
Screening for antimicrobial activity against microorganisms 
including bacteria such as Bacillus sp., Proteus sp. and 
Staphylococcus aureus was carried out to determine whether 
the mushroom extracts possessed any biological activity. 
Antimicrobial activity was measured by agar well diffusion 
assay.  Fresh cultures of test bacterial strains were grown 
overnight in nutrient broth to get 105 CFU/ml.  0.1ml of each 
bacterial suspension was used to inoculate individual 
petridish containing nutrient agar medium with a sterile 
non-toxic cotton swab on a wooden applicator. Eight 
millimeter diameter 5 wells were punched in the agar plates.  
Aliquots (25 µl, 50 µl, 75 µl, 100 µl and 125 µl) of the various 
mycelial extracts were used to fill the wells.  The plates were 
incubated at 28 ± 2°C overnight. Anti-bacterial activity was 
recorded by measuring the zone of growth inhibition around 
the well.  
Anti-haemolytic activity 
By centrifugation the erythrocytes from cow blood were 
separated and washed with phosphate buffer (pH 7.4). With 
phosphate buffered saline the erythrocytes were then 
diluted to give 4% suspension. To 2ml of the erythrocyte 
suspension 500μg of extract/ml of saline buffer were added 
and with saline buffer the volume was made up to 5ml. At 
room temperature the mixture was incubated for 5 min and 
in saline buffer 0.5ml of H2O2 solution was added to induce 
the oxidative degradation of the membrane lipids. The 
concentration of H2O2 in the reaction mixture was adjusted 
to bring about 90% haemolysis of blood cells after 240 min. 
After incubation the reaction mixture was centrifuged at 
1500 rpm for 10 min and the extend of haemolysis was 
determined by measuring the absorbance at 540nm 
corresponding to haemoglobin liberation. The percentage of 
haemolysis was calculated by using the formula [(A0-A1)/A0)] 
X100, where A0 is the absorbance of the control (reaction 
mixture without extract) and A1 is the absorbance of the 
extract/ standard. 
RESULT AND DISCUSSION 
Screening for antibacterial activity against microorganisms 
including bacteria such as Bacillus sp., Proteus sp. and 
Staphylococcus aureus was carried out to determine whether 
the extracts of Basidiomycetes mushroom fungi shows any 
biological activity.  
  
Table 1: The antimicrobial activity of P. citrinopileatus, P. eous and P. cystidiosis 
Test organism Concentration (µl) Zone of inhibition diameter (cm) 
  Pleurotus citrinopileatus Pleurotus eous Pleurotus cystidiosis 











25 1.2 1.5 0.6 1.3 1.0 0.6 0.9 1.0 0.8 
50 1.5 1.8 0.8 1.4 1.1 0.8 1.0 1.5 1.1 
75 2.1 2.4 1.0 1.7 1.2 1.1 1.1 1.7 1.3 
100 1.9 2.1 1.3 1.9 1.3 1.3 1.3 1.6 1.5 
125 1.8 2.3 1.2 1.9 1.1 1.2 1.7 1.8 1.8 
Proteus sp. 
25 0.8 1.2 0.9 1.1 1.0 0.8 1.0 1.0 1.1 
50 0.6 1.5 0.6 1.2 0.8 0.9 1.1 1.2 1.2 
75 0.8 1.7 0.9 1.5 0.9 1.0 1.2 1.8 1.4 
100 1.1 1.6 1.0 1.6 1.1 1.3 1.5 2.2 1.8 





25 1.0 1.5 0.4 1.1 1.1 0.7 1.0 1.2 1.0 
50 1.1 1.7 0.8 1.3 1.5 1.0 1.3 1.4 1.1 
75 1.3 1.8 1.9 1.6 1.6 1.4 1.4 1.6 1.6 
100 1.9 2.1 1.1 1.8 1.6 1.4 1.5 1.7 1.8 
125 1.9 1.9 1.2 1.7 1.8 1.6 1.4 1.7 1.7 
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The result of the evaluation revealed that hexane extract of 
Pleurotus pulmonarius showed the significant activity, 
acetone extract of Schizophyllum commune showed the 
moderate activity and hexane extract of Pleurotus eryngii 
showed the least activity. 
 
Table 2: The antimicrobial activity of P. ostreatus, P. eryngii and P. flabellatus 
Test organism Concentration (µl) Zone of inhibition diameter (cm) 
  Pleurotus ostreatus Pleurotus eryngii Pleuoruts flabellatus 











25 1.2 1.7 0.7 1.2 0.2 0.9 0.8 1.0 0.5 
50 1.6 2.0 0.9 2.1 0.5 1.0 0.9 1.1 0.8 
75 1.8 2.2 1.1 2.2 0.8 1.0 1.0 2.1 1.0 
100 1.9 2.1 1.5 2.0 1.1 1.1 1.0 2.0 1.1 
125 1.9 2.3 1.6 2.1 1.0 1.3 1.3 2.2 1.2 
Proteus sp. 
25 1.1 1.5 1.0 1.3 0.5 1.1 1.2 1.0 1.0 
50 1.3 1.7 1.3 1.5 0.5 1.2 1.3 1.1 1.0 
75 1.5 1.8 1.4 1.6 0.9 1.2 1.5 1.5 1.1 
100 1.4 1.8 1.4 1.6 1.0 1.3 1.8 1.7 1.3 





25 1.0 1.4 1.2 1.6 0.5 1.2 1.2 1.6 1.0 
50 1.2 1.6 1.4 1.9 0.7 1.4 1.3 1.9 1.1 
75 1.3 1.7 1.5 1.8 1.2 1.3 1.5 1.7 1.2 
100 1.7 2.1 1.6 2.0 1.3 1.5 1.8 2.1 1.2 
125 1.6 2.2 1.8 2.1 1.3 1.6 1.9 2.2 1.5 
 
Table 3: The antimicrobial activity of P. florida, P. pulmonarius and S. commune 
Test organism Concentration (µl) Zone of inhibition diameter (cm) 
  Pleurotus florida Pleurotus pulmonarius Schizophyllum commune 











25 1.1 1.5 1.0 1.2 1.8 1.0 1.4 1.0 0.5 
50 1.4 1.6 1.1 1.8 2.1 1.3 1.8 1.5 0.7 
75 1.4 1.4 1.3 1.8 2.2 1.3 1.7 1.7 1.0 
100 1.8 2.0 1.3 1.9 2.5 1.5 1.9 1.8 1.2 
125 1.9 2.2 1.8 2.0 2.3 1.8 2.2 2.0 1.5 
Proteus sp. 
25 1.1 1.3 0.8 1.0 1.2 0.9 1.3 1.1 1.2 
50 1.3 1.5 1.0 1.2 1.8 1.1 1.7 1.4 1.4 
75 1.4 1.6 1.3 1.3 1.9 1.3 1.9 1.4 1.5 
100 1.4 1.8 1.4 1.7 2.2 1.4 2.0 1.6 1.8 





25 1.1 1.6 0.9 1.4 1.8 1.0 1.1 0.9 0.7 
50 1.6 1.7 1.2 1.5 1.8 1.1 1.5 0.8 1.2 
75 1.8 1.9 1.6 1.7 2.0 1.2 1.9 1.2 1.2 
100 2.0 2.2 1.9 1.7 2.1 1.2 2.1 1.3 1.5 
125 2.1 2.3 1.9 1.8 2.3 1.5 2.2 1.8 1.6 
 
Lipid oxidation of cow blood erythrocytes membrane 
mediated by hydrogen peroxide induces membrane damage 
and subsequent haemolysis. The result of the evaluation 
revealed that hexane extract of Pleurotus pulmonarius has 
high significant efficiency in inhibiting radical induced red 
blood cell haemolysis with 97.39%. 
 
 
Figure 1: Anti-hemolytic activity of selected mushroom fungi 
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CONCLUSION 
The significant pharmacological effects and physiological 
properties of mushrooms are bio regulation (immune 
enhancement), maintenance of homeostasis and regulation 
of biorhythm, cure of various diseases and prevention and 
improvement from life threatening diseases such as cancer, 
cerebral stroke and heart diseases. Haemolyses has a long 
history of use in measuring free radical damage and its 
inhibition by antioxidants but only few studies have been 
performed with erythrocytes in whole blood. In this study, 
use of biological test based on free radical induced 
erythrocytes lysis in cow blood was performed. Lipid 
oxidation of cow blood erythrocytes membrane mediated by 
H2O2 induced membrane damage and subsequently 
haemolysis. A high significant efficiency in inhibiting radical 
induced red blood cell haemolyses was observed for that the 
hexane extract of Pleurotus pulmonarius. Edible 
Basidiomycetes mushroom fungi which taken for our 
investigation were act as a non-antibiotic alternative for 
preventing many bacterial diseases. Meanwhile all the 
extracts showed effective antimicrobial activities among 
which the hexane extract of Pleurotus pulmonarius showed 
high significant antimicrobial activity. Using these edible 
Basidiomycetes mushroom fungi leads to reducing amount 
of antibiotics prescribed for treatment of bacterial diseases 
and preventing drug resistance. This study demonstrated 
that the extracts of edible Basidiomycetes mushroom fungi 
act as a modern medicine for bacterial diseases. The 
advanced pharmacological screening of these edible plants 
using the modern tool may leads to some new drug. 
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